Phenotypic profiling of pristane‐induced mimicking human systemic lupus erythematosus in Macaca fascicularis
Authors:
- Jonny JonnyJJJonny Jonny
- Soetojo WirjopranotoSWSoetojo Wirjopranoto
- Chairul A. NidomCNChairul A. Nidom
- I Ketut SudianaISI Ketut Sudiana
- Terawan A. PutrantoTPTerawan A. Putranto
- Elisa D. PratiwiEPElisa D. Pratiwi
- Tiza W. MawaddahTMTiza W. Mawaddah
- Astria N. NidomANAstria N. Nidom
- Reviany V. NidomRNReviany V. Nidom
- Setyarina IndrasariSISetyarina Indrasari
- Irma Y. RosytaniaIRIrma Y. Rosytania
- Hiqmah Y. YanaHYHiqmah Y. Yana
Open Access
- 15 March 2026
- journal article
- Published by Wiley in Animal Models and Experimental Medicine
Abstract
Background: The development of nonhuman primate models that replicate human systemic lupus erythematosus (SLE) remains limited. This study aimed to develop a pristane‐induced SLE model in Macaca fascicularis and evaluate its capacity to mimic human‐like clinical and laboratory immunological alterations. Methods: An experimental, single‐arm investigation was performed using six female M. fascicularis (2–3 years old, 3–4 kg), which received a single intraperitoneal pristane injection (5 mL/kg body weight) to induce SLE and were monitored biweekly. Results: Throughout the 24‐week study period, all macaques developed hallmark SLE‐like changes without requiring a booster, including a pronounced increase in antinuclear antibody titers ( p = 0.002), with anti‐dsDNA positivity detected at the study endpoint. Significant decline was observed in hemoglobin, leukocyte, and lymphocyte count ( p < 0.05), reflecting hematologic perturbations consistent with human SLE. Physiologic deterioration, manifested as hyperthermia and weight loss, also emerged early ( p = 0.001). Biochemical assessment demonstrated mild hepatic and renal dysfunction marked by elevated serum glutamic pyruvic transaminase (SGPT) and urea concentrations ( p < 0.05). Uniform proteinuria further indicated renal involvement, although the absence of hematuria suggests a spectrum of renal injury that may be less severe than that observed in advanced human SLE and may require longer observation. Conclusion: Overall, the reproducibility of autoantibody elevation and multisystem involvement demonstrates the model's translational potential. This nonhuman primate model offers a significant framework for investigating SLE pathogenesis and assessing novel therapy approaches.Keywords
This publication has 37 references indexed in Scilit:
- Immune cell alterations in a pristane‐induced lupus model in C57BL/6J miceRheumatology & Autoimmunity, 2025
- Improved diagnosis of systemic lupus erythematosus with human-derived double-stranded DNA antigenBiosensors and Bioelectronics, 2024
- Antinuclear Antibody Testing for the Diagnosis of Systemic Lupus ErythematosusMedical Clinics of North America, 2021
- Abnormal thymic B cell activation and impaired T cell differentiation in pristane-induced lupus miceImmunology Letters, 2021
- Oxidative stress and immune complexes: Pathogenic mechanisms in pristane induced murine model of lupusImmunobiology, 2020
- Animal Models in Lupus2018
- A pathophysiology-based approach to the diagnosis and treatment of lupus nephritisKidney International, 2016
- Liver enzyme abnormalities in systemic lupus erythematosus: a focus on toxic hepatitisRheumatology International, 2009
- Induction of autoimmunity by pristane and other naturally occurring hydrocarbonsTrends in Immunology, 2009
- Anti‐histones antibodies in systemic lupus erythematosus: prevalence and frequency in neuropsychiatric lupusJournal of Clinical Laboratory Analysis, 2008